Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypertension as a Metabolic Disorder and the Novel Role of the Gut
Masami Tanaka, Hiroshi Itoh
Current Hypertension Reports (2019) Vol. 21, Iss. 8
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Inter-organ cross-talk in metabolic syndrome
Christina Priest, Peter Tontonoz
Nature Metabolism (2019) Vol. 1, Iss. 12, pp. 1177-1188
Closed Access | Times Cited: 215
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19
Shigeru Shibata, Hisatomi Arima, Kei Asayama, et al.
Hypertension Research (2020) Vol. 43, Iss. 10, pp. 1028-1046
Open Access | Times Cited: 170
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review
Kin Israel Notarte, Abbygail Therese Ver, Jacqueline Veronica Velasco, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 6, pp. 373-390
Open Access | Times Cited: 89
Recent advances in modulation of cardiovascular diseases by the gut microbiota
Sepiso K. Masenga, Benson M. Hamooya, Joy Hangoma, et al.
Journal of Human Hypertension (2022) Vol. 36, Iss. 11, pp. 952-959
Open Access | Times Cited: 76
Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors
Christopher S. Wilcox
Hypertension (2020) Vol. 75, Iss. 4, pp. 894-901
Open Access | Times Cited: 121
Improving obesity and blood pressure
Masami Tanaka
Hypertension Research (2019) Vol. 43, Iss. 2, pp. 79-89
Closed Access | Times Cited: 83
Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment
Fan Yang, Hengwen Chen, Yonghong Gao, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110503-110503
Open Access | Times Cited: 81
Ketogenic Diet: A Dietary Intervention via Gut Microbiome Modulation for the Treatment of Neurological and Nutritional Disorders (a Narrative Review)
Jun-Ming Lim, Vengadesh Letchumanan, Loh Teng‐Hern Tan, et al.
Nutrients (2022) Vol. 14, Iss. 17, pp. 3566-3566
Open Access | Times Cited: 41
Does the Composition of Gut Microbiota Affect Hypertension? Molecular Mechanisms Involved in Increasing Blood Pressure
Julita Tokarek, Emilian Budny, Maciej Saar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1377-1377
Open Access | Times Cited: 21
TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies
Wanqin Zhang, Yunjiao Wang, Ao Zhang, et al.
Journal of Cardiovascular Translational Research (2021) Vol. 14, Iss. 6, pp. 1117-1124
Closed Access | Times Cited: 43
Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
Cameron G. McCarthy, Piu Saha, Rachel M. Golonka, et al.
Comprehensive physiology (2021), pp. 1575-1589
Open Access | Times Cited: 41
Antihypertensive effect of soybean bioactive peptides: A review
Tingna Li, Xiaorui Zhang, Yuanyuan Ren, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 74-81
Closed Access | Times Cited: 41
Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19—A Narrative Review
Emilia Bielecka, Piotr Sielatycki, Paulina Pietraszko, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1837-1837
Open Access | Times Cited: 6
New drug targets for hypertension: A literature review
Qiannan Gao, Li Xu, Jun Cai
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1867, Iss. 3, pp. 166037-166037
Open Access | Times Cited: 43
Cardiac Autonomic Neuropathy: A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders
Nour‐Mounira Z. Bakkar, Haneen S. Dwaib, Souha Fares, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9005-9005
Open Access | Times Cited: 40
Advances on the Experimental Research in Resistant Hypertension
Maria Cláudia Irigoyen, Cláudia Fetter, Kátia De Angelis
Current Hypertension Reports (2024) Vol. 26, Iss. 12, pp. 475-482
Closed Access | Times Cited: 4
The role of gut microbiota and probiotics in managing hypertensive disorders of pregnancy
Roya Abedi Soleimani, Samira Salemkhoei, Payam Gonbari Milani, et al.
Gastrointestinal Nursing (2025) Vol. 23, Iss. 1, pp. 42-48
Closed Access
Elevated isoleucine may be a protective factor for primary hypertension: A pooled causal effect study
Ying Shi, Hairun Liu, Yi Chen
Medicine (2025) Vol. 104, Iss. 9, pp. e41651-e41651
Open Access
FEATURES OF ARTERIAL HYPERTENSION CLINICAL COURSE IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE AND IRRITABLE BOWEL SYNDROME
O. A. Kyrian, A. E. Dorofeyev, В. І. Тарасова, et al.
Bulletin of Problems Biology and Medicine (2025) Vol. 1, Iss. 1, pp. 200-200
Open Access
Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
Adonis Sfera, Carolina Osorio, Carlos Manuel Zapata Martín del Campo, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 27
Selenium-enriched and ordinary green tea extracts prevent high blood pressure and alter gut microbiota composition of hypertensive rats caused by high-salt diet
Meirong Wu, Xiaobin Wu, Jiangxiong Zhu, et al.
Food Science and Human Wellness (2022) Vol. 11, Iss. 3, pp. 738-751
Open Access | Times Cited: 21
Orexin and MCH neurons: regulators of sleep and metabolism
Hanan Bouâouda, Pawan Kumar Jha
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
Unveiling the neuroprotective properties of isoflavones: current evidence, molecular mechanisms and future perspectives
Guowei Gong, Kumar Ganesan, Yukai Wan, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-37
Closed Access | Times Cited: 3
NOX4‐dependent regulation of ENaC in hypertension and diabetic kidney disease
Tengis S. Pavlov, Oleg Palygin, Elena Isaeva, et al.
The FASEB Journal (2020) Vol. 34, Iss. 10, pp. 13396-13408
Open Access | Times Cited: 31
The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension
Waleed N. Qaddumi, Pedro A. José
Biomedicines (2021) Vol. 9, Iss. 2, pp. 139-139
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top